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ABSTRACT 
Protein Antibiotic of Phage M 
Lorna Min 
Department of Biochemistry and Biophysics 
Texas A&M University 
 
Research Advisor: Dr. Ryland Young 
Department of Biochemistry and Biophysics 
 
Phage mediated lysis of bacteria is one of the most common events in the biosphere, and a 
greater understanding of phage lysis mechanisms may lead to the development of novel 
antibacterial therapies.  As they encode a single, nonezymatic protein (“protein antibiotic) to 
effect lysis, small lytic phages offer great promise. The lysis proteins E and A2 of prototypical 
small phages X174 (Microviridae) and Qβ (Alloleviviridae) inhibit cell wall biosynthesis and 
cause lysis at the septum of a dividing cell.  The lysis protein L of prototypical small phage MS2 
(Leviviridae), conversely, causes lysis at random regions of the cell through an unknown 
mechanism. Although MS2 and phage M belong to the Leviviridae family, their lysis genes L 
and M lys have evolved at different locations (figure 1A) and cause different lysis phenotypes 
(figure 1B). 
 
In this project, we investigated the lysis mechanism of M Lys. Based on similarities in 
membrane topology and lysis phenotype, we hypothesized that M Lys, like E, inhibits cell wall 
biosynthesis. Isolation of host mutants resistant to lysis yielded mutations in murJ, a proposed E. 
coli lipid II flippase involved in transporting cell wall precursors from the cell interior to the 
exterior. This suggests that M Lys confers lysis by inhibiting MurJ and thus host cell wall 
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biosynthesis. This also provides additional support for the identification of MurJ as the E. coli 
lipid II flippase. 
 
 
Figure 1. Small lytic phages of the Leviviridae genus display a range of lysis phenotypes and genetic architectures. 
(A) Leviviridae phages have evolved three distinct genetic architectures regarding lysis gene location. 
(B) M Lys causes septal lysis in E. coli while L causes random blebbing. 
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CHAPTER I 
INTRODUCTION 
 
The rise in antibiotic resistance 
The over-prescription of antibiotics has contributed to an increase in antibiotic resistance, and 
previously easily treatable bacterial infections are now becoming increasingly difficult to treat. 
Enterobacteriaceae, a family of Gram-negative bacteria including many commonly known 
pathogens such as Escherichia coli, Salmonella, and Shigella, have been slow to adapt antibiotic 
resistance to broad spectrum antibiotics. Even when Enterobacteriaceae began exhibiting multi-
drug resistance, physicians have previously been able to administer a class of antibiotics called 
carbapenems as a last resort. Although carbapenems belong to the same class of antibiotics as 
penicillins and cephalosporins, they affect a wider range of bacteria and have resisted antibiotic 
resistance. Despite this, Enterobacteriaceae resistant to all or almost all of currently known 
antibiotics, including carbapenems, have become more prevalent and are associated with ever 
higher mortality rates [1, 2]. 
 
As a cell component unique to bacteria and vital to maintaining structural integrity, the cell wall, 
made of peptidoglycan (PG, also known as murein), is a common target for antibiotics such as 
penicillin and carbapenems. Indeed, most antibiotics currently in use inhibit PG biosynthesis, 
causing cells to lyse as their high internal osmotic pressure overcomes the strength of the inner 
and outer membranes [2]. Pharmaceutical antibiotics, however, are not the only molecules found 
to target PG biosynthesis; bacteriophages, known in short as phages, are natural predators of 
bacteria that have evolved proteins targeting PG as well [3]. 
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PG precursors and biosynthesis 
The main difference between Gram-negative and Gram-positive bacteria is the presence or 
absence of an outer membrane (OM). The OM stabilizes the inner membrane (IM) of Gram-
negative bacteria, resulting in a relatively thin PG meshwork (<10 nm). In contrast, Gram-
positive bacteria rely on a thick PG layer (30-100 nm) to compensate for the absence of an OM. 
As the cell wall is vital to structural integrity, PG biosynthesis must be strictly regulated to avoid 
breaches during cell growth and division [4]. 
 
PG is a polymer made of repeating units of cross linked disaccharide polypeptides, and its 
biosynthetic pathway can be divided into three stages. The first stage occurs in the cytoplasm and 
begins with the synthesis of the UDP-N-acetylmuramyl-pentapeptide (UDP-MurNAc-PP) 
precursor from UDP-N-acetylglucosamine (UDP-GlcNAc) by MurA. In Gram-negative bacteria, 
this pentapeptide consists of L-alanine-γ-D-glutamate-diaminopimelate(meso-DAP)-D-alanine-
D-alanine (L-ala-D-glu-mDAP-L-lys-D-ala-D-ala) (Sobhanifar). From here, the integral IM 
protein MraY catalyzes formation of the first IM lipid intermediate, lipid I, from the carrier lipid 
undecaprenyl (also known as bactoprenol) and UDP-MurNAc-PP, and the peripheral membrane 
protein MurG catalyzes formation of the second inner membrane lipid intermediate, lipid II, 
from lipid I and UDP-GlcNAc. Lipid II is then transported from the cytoplasmic leaflet of the IM 
to the periplasmic leaflet, where the intact PG layer is degraded by autolysins and the 
transglycosylase and transpeptidase activities of various penicillin-binding proteins (PBPs) add 
the GlcNAc-MurNAc disaccharide pentapeptide PG precursor to the growing PG layer [5]. 
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Lipid II and its flippase 
As the final intermediate before the addition of PG precursors to the PG layer, lipid II is essential 
to PG biosynthesis and is targeted by many antibiotics. Bacitracin, for example, prevents the 
carrier lipid undecaprenyl phosphate from being recycled, preventing lipid II synthesis. 
Glycopeptides like vancomycin, on the other hand, bind to lipid II terminal D-alanine residues, 
preventing crosslinking. Additionally, lipid II modifications are slow to develop, leading to 
relatively low rates of antibiotic resistance. Vancomycin resistance, for example, only developed 
30 years after clinical use when bacteria began utilizing a terminal D-alanine-D-lactate in lipid II 
instead of D-ala-D-ala [2]. 
 
The enzyme catalyzing the transport of lipid II from the cytoplasm to the periplasm, then, is also 
vital to PG biosynthesis as it connects the cytoplasmic synthesis of PG precursors to the addition 
of precursors to the PG layer. Lipid II is an amphipathic molecule -- the undecaprenyl moiety is a 
long hydrophobic molecule and the attached disaccharide pentapeptide is hydrophilic -- and 
cannot simply diffuse across the membrane. An IM enzyme containing a hydrophilic cavity must 
therefore transport lipid II across the IM. In the current model of transport, a flippase catalyzes 
the “flipping” of the hydrophilic disaccharide pentapeptide through the hydrophilic cavity while 
the hydrophobic undecaprenyl phosphate remains in the hydrophobic core of the IM. 
Controversy surrounds the identity of this flippase in E. coli, though, with two main contenders: 
FtsW and MurJ [6]. 
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FtsW as the lipid II flippase 
It has been recognized that the lipid II flippase must be an IM protein, conserved among gram 
negative bacteria synthesizing PG, absent in bacteria not synthesizing PG, and essential to cell 
survival. Based on these criteria, FtsW was proposed to be the missing lipid II flippase. FtsW 
and its two homologs RodA and SpoVE are members of the SEDS (shape, elongation, division 
and sporulation) family, members of which can be found in bacteria synthesizing PG. FtsW, 
RodA, and SpoVE (found in Bacillus subtilis) are vital to cell division, elongation, and 
sporulation respectively, and can be found complexed with various PBPs. In addition, FtsW of 
E.coli is located in the same operon as PBP3 and MurG, the PG biosynthesis enzyme catalyzing 
lipid II synthesis, and is known to localize to the cell septum during cell division. This suggests 
that FtsW may act as the lipid II flippase during cell division and, by homology, RodA and 
SpoVE may act as the lipid II flippase during cell elongation and sporulation respectively [7]. 
 
One impediment in identifying the lipid II flippase is the lack of an assay to determine flipping 
activity. Mohammadi et al., 2011 developed an in vitro fluorescence-transfer assay in which a 
decrease in fluorescence of a lipid II derivative and a subsequent increase in fluorescence of a 
vancomycin derivative indicated lipid II flipping activity. Vancomycin is an antibiotic that 
inhibits PG biosynthesis by binding to the terminal D-alanine-D-alanine residues on the 
disaccharide pentapeptide PG precursor of lipid II. As vancomycin cannot penetrate the IM, the 
observation of such fluorescence is indicative of lipid II flipping [7]. 
 
Mohammadi et al., 2011 showed that overexpression of FtsW in E. coli membrane derived 
vesicles led to an increase in the change in fluorescence indicative of lipid II flipping activity. 
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Furthermore, deletion of FtsW from membrane derived vesicles largely resulted in a deletion of 
lipid II flipping associated fluorescence; residual fluorescence was attributed to RodA activity. 
Additionally, a dithionite reduction assay in which dithionite reduced fluorescence of flipped 
lipid II derivatives showed that the presence of purified FtsW in large unilamellar vesicles 
resulted in a decrease of fluorescence. Neither of these assays displayed lipid II flipping activity 
in the presence of MurJ, leading the authors to conclude that FtsW alone is the E. coli lipid II 
flippase [7]. 
 
Several factors in experimental design may have affected the results of this in vitro assay, 
though, including the introduction of lipid II precursors through a freeze-thaw method, the 
reliance on a lipid II derivative that may display different flipping activity than wild type lipid II, 
and the fact that this assay was conducted at 14°C to prevent loss of lipid II fluorescence by 
transglycosylase activity not indicative of lipid II flipping and vancomycin binding [8]. 
Additionally, this assay did not address the selectivity of FtsW lipid transport [6]. 
 
MurJ as the lipid II flippase 
Ruiz et al., 2008, on the other hand, initially identified MurJ as the sole lipid II flippase in E. coli 
using a reductionist bioinformatics search. MurJ sequence homologs are present in non-bacterial 
organisms producing PG and archaea producing PG-like molecules, supporting this hypothesis. 
MurJ is also a member of the multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) exporter 
superfamily, sharing greatest sequence homology to the Wzx flippases of the polysaccharide 
transporter (PST) family that flip lipid II-like undecaprenyl-linked saccharide precursors across 
the IM to the periplasm. FtsW was ruled out as a possible lipid II flippase due to its presence in 
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several PG-less bacteria and absence in other PG-synthesizing bacteria. Additionally depletion of 
MurJ was shown to lead to a decrease in cell density indicative of cell lysis, and incorporation of 
3H-mDAP, the third amino acid of the disaccharide pentapeptide PG precursor, decreased in 
MurJ-depleted cells after several generations [9]. 
 
A subsequent structural functional analysis of MurJ in silico using the I-TASSER server revealed 
structural similarity between MurJ and members of the multidrug and toxic compound extrusion 
(MATE) family, also members of the MOP superfamily. Proteins of the MATE family are Na+ 
and H+ driven antiporters that transport hydrophobic and amphiphobic molecules across the IM 
and contain 12 TMDs bundled into two groups of 6 helices. These proteins contain a central 
cavity through which molecules are transported and exist in two V-shaped conformations, one 
with the central cavity open to the cytoplasm and one with the central cavity open to the 
periplasm. Through in silico modeling and in vivo experiments, MurJ was shown to have 14 
TMDs with an N-in, C-in topology and TMDs 1, 2, 7, and 8 surrounding a positively charged, 
solvent-exposed central cavity, suggesting a possible function transporting the negatively 
charged disaccharide pentapeptide of lipid II [10]. 
 
The development of an in vivo assay linking MurJ to lipid II flippase activity further cemented 
the identification of MurJ as the E. coli lipid II flippase. In this assay, cells were treated with the 
protein toxin colicin M (ColM). Upon treatment, ColM is transported into periplasm where it 
cleaves the disaccharide pentapeptide moiety from lipid II. This disaccharide pentapeptide is 
then further processed by periplasmic carboxypeptidases to yield disaccharide tetrapeptides. As 
the IM is impermeable to ColM, ColM activity is specific for periplasmic lipid II, and the 
11 
 
appearance of disaccharide tetrapeptides is indicative of lipid II flipping. Lipid II flipping was 
eliminated upon MurJ inactivation, but continued despite FtsW reduction in ΔrodA mutants, 
indicating that FtsW and RodA play no part in lipid II flipping [11]. 
 
Still, critics of MurJ argue, although in vivo assays can help pinpoint the function of a protein, 
they do not necessarily demonstrate a direct relationship between a protein and its putative 
function; there are numerous additional variables that may affect the observed activity. The lack 
of observed lipid II flippase activity upon MurJ inactivation in the in vivo assay, for example, 
may simply arise from the inherent insensitivity of the assay. Only in vitro systems expressing a 
single protein can demonstrate a direct relationship between protein and function, and the lack of 
lipid II flippase activity upon MurJ expression in the in vitro assay developed suggests that FtsW 
is the flippase instead [6]. 
 
Alternatively, MurJ and FtsW may both act as lipid II flippases, and the results of the ColM 
assay may simply demonstrate that FtsW exists in a large protein complex with MurG and PBP3 
while MurJ exists as a lone IM protein. As such, lipid II would be more inaccessible to ColM due 
to the size of the protein complex and perhaps the quicker transfer of lipid II from FsW to PBP3. 
The essentiality of both MurJ and FtsW, however, seems to suggest that the two serve two non-
redundant functions [6]. 
 
Lytic bacteriophage life cycle 
Phages are viruses that infect solely bacteria. Lytic phages can be divided into two classes based 
on genome size: large phages that utilize double stranded DNA (dsDNA) anywhere from 20 kb 
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to 300+ kb long; and small phages that utilize single stranded genomes about 4 kb long. 
Although these phages differ drastically in genome size, they follow the same general life cycle 
in which they inject their genetic material into a bacterial host, use host machinery and resources 
to reproduce themselves, and eventually lyse their host and release progeny into the environment 
(figure 2). This last step of lysis is particularly important to phage propagation as it allows 
progeny phages to escape the confines of the bacterial host [3]. 
 
 
Figure 2. Typical bacteriophage life cycle. 
 
Lysis in large double stranded DNA lytic phages 
 
Canonical holin-endolysin system 
Large phages have evolved two systems of degrading the cell wall to effect host lysis. In the 
canonical holin-endolysin system, largely studied in phage lambda, holin and endolysin proteins 
are expressed about 8-10 minutes after infection during late gene expression. Homodimers of 
holins accumulate harmlessly and randomly in the inner membrane while monomers of active 
endolysins accumulate in the cytoplasm. This occurs simultaneously with morphogenesis of 
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progeny phages. About 50 minutes after infection upon reaching a critical concentration, holins 
are triggered and begin aggregating into 1-3 micron sized rafts. These rafts are thought to create 
holes in the inner membrane (IM), allowing endolysins to escape the cytoplasm and unleash their 
muralytic activity on the cell wall. The cell membrane bulges out at the site of holin raft 
formation as the internal osmotic pressure overcomes the integrity of the outer membrane (OM), 
and the cell eventually lyses [3]. 
 
Interestingly, disturbing the proton motive force (PMF) across the IM causes premature holin 
triggering. It is thought that aggregation of holins into rafts disturbs PMF, and that this 
disturbance of PMF in turn encourages further holin aggregation and eventual hole formation [3]. 
 
Pinholin-SAR-endolysin system 
The pinholin-SAR-endolysin system has been studied largely in the coliphage P1 and the 
lambdoid phage 21. SAR endolysins from phage P1 and phage 21 contain a SAR (signal-anchor-
release) domain that allows them to be secreted to the periplasm in their inactive form through 
the host sec system. This initial inactivity allows SAR endolysin muralytic activity to be 
regulated by pinholin triggering. Unlike other proteins secreted through the sec system, the 
signal domain of SAR is not cleaved upon secretion. SAR endolysins therefore remain anchored 
to the periplasmic leaflet of the IM until the SAR domain disengages from both the enzyme and 
the IM, either slowly and spontaneously or quickly upon disruption of PMF. With the help of the 
free SAR domain, the released enzyme refolds into its active form and begins degrading the cell 
wall. Because SAR endolysins are distributed evenly through the IM, activation results in even 
degradation of the cell wall. The cell then appears to shorten before eventually lysing [3]. 
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Unlike in the canonical holin-endolysin system, pinholins from phage 21 do not play a role in 
transporting SAR endolysins from the cytoplasm to the periplasm. Instead, they accumulate 
harmlessly in the IM until they are triggered, when they aggregate in heptamers to form about 103 
small channels that disrupt PMF. Pinholins, much like holins, then, regulate the timing of lysis 
[3]. 
 
Degradation of the cell wall by coordinated action of holins and spanins in lambda is regulated 
by a dual-start motif in which the holin encoding gene is translated at two sites, one yielding a 
holin and one yielding a slightly longer antiholin. In lambda, anti-holins heterodimerize to 
holins, preventing homodimerization of holins and subsequent aggregation. The ratio of 
holin:antiholin is about 2:1, and heterodimerization of anti-holins and holins controls the timing 
of lysis [3]. 
 
Regulation of timing of lysis 
Dual-start motifs have been also been found in other holins, like the pinholin of phage 21 and the 
holin of T4. Although the anti-holins encoded by lambda and phage 21 act similarly, the 
antiholin of T4 acts by a completely different mechanism. T4 encodes a holin consisting of one 
transmembrane domain (TMD) and a periplasmic domain. If the antiholin is activated, 
presumably in conditions where there are few or no surrounding hosts to infect, it binds to this 
periplasmic domain and prevents hole formation. This is the only known form of holin inhibition 
that actively inhibits holin function [3]. 
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Spanins 
Although the cell wall is a large barrier imposed by the host, simply degrading the cell wall is 
not to effect lysis. A third group of proteins called spanins, so named because they span the 
periplasm, is necessary for lysis (Young 2014). Spanin deficient mutants round up into spheres 
instead of lysing as the cell wall responsible for cell shape is degraded. Only the OM is intact at 
this point in time, suggesting that spanins must disrupt OM integrity in lysing the cell [12]. 
 
I-spanins and o-spanins 
There are two classes of spanins: spanins consisting of an inner membrane subunit (i-spanins) 
and an outer membrane subunit (o-spanins); and unimolecular spanins (u-spanins); Lambda 
encodes this first spanin where the i-spanin Rz is an inner membrane protein with an N-in, C-out 
topology and the o-spanin Rz1 is an N-terminus outer membrane lipid-associated protein.. Rz1, 
interestingly enough, is embedded in the +1 reading frame of Rz. The discovery of Rz1 in Rz was 
the first time one gene was found in a different reading frame of another gene participating in the 
same biological function. The lysis genes E and L of ssDNA phage ΦX174 and ssRNA phage 
MS2, respectively, were previously found embedded in different reading frames of other gene, 
but these genes were of different functions separate from lysis [3]. 
 
The identification of Rz1 as the o-spanin was supported by the presence of a strong Shine-
Delgarno sequence and a strong signal peptidase II cleavage motif, or lipobox. Members of the 
signal peptidase II class cleave the signal domain from lipoprotein precursors at and modify the 
cleaved cysteine residue with a lipid (Inderjit), indicating that Rz1 is a lipoprotein. The presence 
of threonine and serine residues in the +1 and +2 positions after the lipid-modified cysteine in 
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particular suggests that Rz1 is transported to the OM by the Lol system, further supporting the 
identification of Rz1 as the o-spanin [3]. 
 
Upon further analysis of Rz and Rz1 homologues in other phages, three distinct genetic 
architectures have been discovered: embedded, as with Rz and Rz1; overlapping, in which the 
Rz1 reading frame begins in the Rz reading frame but extends past Rz termination; and separate, 
in which Rz1 is immediately downstream of Rz. Embedded i-spanins and o-spanins are proposed 
to have evolved from separate genes that, over time, evolved to interact with each other in order 
to effect lysis. It is thought that, over time, overlapping and embedded i-spanins were favored 
because of the minimal probability of recombination associated which this gene structure; many 
phages undergo a hyper-recombinational state during their infection cycle [3]. 
 
Rz and Rz1 are synthesized and inserted into their respective membranes throughout late gene 
expression. Rz and Rz1 interact with each other at their C termini and thread through spaces in 
the PG in order to span the periplasm. Rz and Rz1 each homodimerize through the formation of 
disulfide bonds; Rz contains two cysteine residues, and Rz1 contains one cysteine residues. 
These disulfide bonds are formed by the periplasmic Dsb system upon secretion through the sec 
system. DsbA in particular promotes homodimerization of either Rz or Rz1, which then 
promotes spontaneous homodimerization of Rz1 or Rz respectively. Homodimers of Rz and Rz1 
then dimerize as well to form a heterotetramer spanin complex. DsbA, however, also promotes 
the formation of intramolecular disulfide bonds in Rz. These intramolecular disulfide bonds in 
Rz must then be reduced by DsbC before Rz homodimerization can occur, whether catalyzed by 
DsbA or homodimerization of Rz1. Similar to the discovery of the RzRz1 genetic structure, this 
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is the first time the Dsb system has been found to promote formation of intermolecular disulfide 
bonds; Dsb had been previously implicated in the formation of intramolecular disulfide bonds 
[3]. 
 
U-spanins 
U-spanins, such as gp11 of phage T1, share characteristics of both i-spanins and o-spanins. Gp11 
has a TMD at one terminus, like i-spanins, and an N-termial lipobox in which the lipid-modified 
cysteine is followed by serine and threonine residues, like o-spanins. Furthermore, gp11 capable 
of rescuing lysis in lambda RzRz1 deficient mutants, supporting the identification of proteins 
such as gp11 as u-spanins [3]. 
 
Proposed mechanisms of action for spanins 
Three mechanisms of action have been proposed for spanins: enzymatic activity, pore formation, 
and membrane fusion. Due to its simplicity and other factors that will be discussed below, 
membrane fusion seems to be the most likely mechanism [3]. 
 
At the very least, enzymatic spanin activity in which spanins cleave PG peptide crosslinking or 
PG peptide links to the OM seems impossible. None of the known RzRz1-like and gp11-like 
proteins share homology to any proteolytic or lipolytic domains. Additionally, assuming that i-
/o-spanin complexes and u-spanins operate in a similar fashion, it is difficult to imagine that 
either is capable of refolding to form a globular enzymatic domain in the periplasm. The length 
of both i-/o-spanin complexes and u-spanins seems to negate this possibility, as both are merely 
capable of spanning the periplasm; the length of the soluble portion of the RzRz1 complex, for 
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example, is on par with the width of the periplasm. The secondary structures of Rz and Rz1 are 
problematic as well. Rz is predicted to contain coiled coil α-helices, and Rz1 is predicted to have 
an unorthodox structure due to its numerous proline residues, neither of which are conducive to 
the fomation of a globular domain [3]. 
 
A second mechanism of action has been proposed in which i-spanins couple to holins, resulting 
in spanin-mediated micron pore formation upon holin triggering [3]. Several problems exist with 
this theory as well, though. P1 lysis, which implements a combination of holins and SAR 
endolysins (as opposed to the canonical holin-endolysin system or the pinholin-SAR-endolysin 
system), has been shown to occur independent of holins [13]. Additionally, assuming that 
spanins function similarly in both phages utilizing holins and phages utilizing pinholins, the size 
of the holes formed by pinholins (about two nm in diameter for phage 21) seems to negate the 
legitimacy of this theory, as the smallest dsDNA phages are about 50 nm in diameter [3]. 
 
By process of elimination and its innate simplicity, the third proposed mechanism in which 
spanins promote fusion of the IM and OM seems the most likely. Purified Rz1 has been found to 
localize in membrane fractions of intermediate density between the IM and OM [14]. 
Additionally, the periplasmic region of Rz consists of two α-helices connected by a hinge, and 
formation of the heterotetramer complex seems to promote α-helical structure and the formation 
of coiled-coils [15]. A mechanism has been proposed, then, in which PG degradation releases 
spanins from the confinement of the PG mesh and allows for intramolecular coiled coil 
formation in spanins. This brings the two membranes together, allowing a catalytic domain in the 
o-spanin to catalyze membrane fusion. Although the periplasmic domain of u-spanins is 
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predicted to consist of several β-sheet structures instead of α-helices, u-spanins are proposed to 
function in a similar manner with intramolecular or intermolecular interactions between β-sheets 
[3]. 
 
Lysis in small single stranded genome lytic phages 
Small lytic phages have an average genome size of 4 kbp. Given that the average gene is 1 kb 
long, most small lytic phages encode only four proteins by which they infect a bacterial host, 
reproduce, and cause lysis. As a result, small lytic phages employ a different lysis mechanism 
than large lytic phages do, instead utilizing single gene lysis (SGL) systems encoding a single 
lysis protein in the amurin class, so named for their lack of muralytic (PG-degrading) activity 
[16]. 
 
There are three prototypical small lytic phages, each encoding a lysis protein with a unique 
mechanism: the ssDNA phage ΦX174 of the Microviridae genus encodes ten proteins, including 
the lysis protein E; the ssRNA phage Qβ of the Alloleviviridae genus and the ssRNA phage MS2 
of the Leviviridae genus each encode a mere four proteins, including the lysis proteins A2 and L 
respectively (figure 3) [16]. 
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Figure 3. Genetic architectures and lysis proteins for prototypical small lytic phages. 
 
The lysis protein E of phage ΦX174 
Phage ΦX174 lysis of E. coli was first studied in Markert and Zillig, 1964 who observed lysis to 
take place over one generation of E. coli as opposed to the quick and abrupt lysis observed in 
dsDNA phage T-even infections. Additionally, the timing and speed of lysis was observed to 
depend on the the growth phase of infected bacteria. Lysis of bacteria infected during stationary 
phase occurred later and at a slower rate than lysis of bacteria infected during log phase, a phase 
indicative of cell growth and division. These observations can be explained by the later deduced 
lysis mechanism [17]. 
 
The lysis gene E is 91 codons long and is embedded in the morphogene D in a +1 reading frame. 
E is an inner membrane protein with an N-out, C-in topology (figure 3) and has been shown to 
be necessary and sufficient for ΦX174 mediated lysis. Before elucidation of the E lysis 
mechanism, several hypotheses existed. E-mediated lysis shares characteristics to penicillin-
mediated lysis; both require cell growth for lysis to occur and cause septal lysis. As penicillin 
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targets the peptide crosslinking step of PG biosynthesis (Ciak), it was hypothesized that E also 
targets PG biosynthesis. Alternatively, E-mediated lysis in hosts with impaired autolytic systems 
was also impaired, giving rise to the hypothesis that E activates the host autolytic system 
normally involved in degrading the cell wall during PG biosynthesis [18]. And the discovery of 
50 nm - 200 nm holes in the cell septum and, occasionally, cell poles, prompted the hypothesis 
that E aggregates to form tunnels spanning the cell envelope [19]. 
 
Roof et al., 1994 isolated an E. coli host mutant named slyD (sensitivity to lysis) which 
displayed a complete block to lysis. This mutant was determined to contain a mutation in a novel 
protein, thereafter named SlyD, which shares homology with the FKBP family of peptidyl-prolyl 
cis-trans isomerases, a protein family shown to interconvert proline residues between the cis and 
trans conformations. E contains five proline residues [20], three of which lie in the TMD 
(Bernhardt 2000), and slyD mutants display decreased levels of E in the IM. It was thus 
hypothesized that SlyD folds E into its active configuration (Roof 1994), stabilizes E, or is 
involved in inserting E into the IM [21]. 
 
E mutants, deemed Epos (plates on slyD), capable of overcoming the slyD block to lysis and 
lysing host cells were found thereafter. To determine the protein targeted by E, host mutants 
resistant to Epos-mediated lysis, named eps (Epos sensitivity), were therefore isolated. Although 
most eps mutants developed lysis resistance by decreasing expression of Epos, several eps 
mutants expressing wildtype levels of Epos were found to contain mutations in the PG 
biosynthesis enzyme MraY [21]. E was thus found to act as a noncompetitive inhibitor of MraY, 
interacting with the enzyme and the enzyme-substrate complex with equal affinity. The location 
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of eps mutations indicates that the TMD of E interacts with MraY at TMD 5 and 9, causing a 
conformational change that decreases MraY activity [22]. This discovery of the protein target of 
E explains the necessity of cell growth and the observance of septal lysis. Cell growth and 
division are marked by increased PG biosynthesis, especially at the septum where new cell wall 
material must be laid down before cell division. Cells are therefore more sensitive to inhibition 
of PG biosynthesis during the log phase and display septal lysis upon PG biosynthesis inhibition. 
Interestingly, even a slight increase in MraY levels blocks E-mediated lysis [23], indicating that 
E expression remains constant at about 500 molecules per cell no matter the conditions [22]. 
 
Further studies by Tanaka et al., 2012 showed that E interacts with MraY specifically in the 
periplasmic leaflet of the inner membrane. The length of the TMD in E and its location in the 
inner membrane are vital to its inhibition of MraY. More specifically, the location of P21 is vital 
to E function. Proline residues produce kinks in the α-helices commonly found in TMD and are 
thought to allow for tighter packing between membrane proteins. This, however, does not to 
seem the function of P21 as moving the proline residue one turn towards the periplasm results in 
decreased function. P21, then, seems to confer a structure necessary for function [24]. 
 
The lysis protein A2 of phage Qβ 
The cytosolic lysis protein A2 has also been shown to be necessary and sufficient for Qβ-
mediated lysis. Interestingly, A2 serves a dual function as the maturation protein (figure 3), 
enabling phage Qβ to adsorb to the host sex pilus and protecting phage genetic material from 
degradation. Like E, A2 also causes septal lysis, supporting the hypothesis that A2 also inhibits 
PG biosynthesis. As 3H-DAP is not incorporated into PG or even the last cytosolic precursor 
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UDP-MruNAc-PP, A2 was proposed to block one of the cytosolic steps of PG biosynthesis. 
Selection of host mutants resistant to lysis yielded two rat (resistance to A-two) mutants, both of 
which contained the same mutation in murA where A2 putatively binds. MurA catalyzes the 
conversion of UDP-GlcNAc and phosphoenolpyrvuate (PEP) to UDP-GlcNAc-enolpyruvate 
(UDP-GlcNAc-EP), the first committed step of PG biosynthesis, and exists in one of three 
conformations: open; closed and bound to UDP-GlcNAc (singly liganded); and closed and bound 
to UDP-GlcNAc and PEP (doubly liganded). Subsequent analysis of the sugar-nucleotides that 
accumulate in cells expressing A2 revealed an accumulation of the MurA substrate UDP-
GlcNAc, further supporting the identification of MurA as the A2 target [25]. 
 
Hatfull 2001 postulated that A2 does not assume MurA inhibitory activity until assembled on a 
complete phage. Such a mechanism would solve the problems of lysis timing and the insolubility 
of free A2. However, Reed et al., 2013 has since found that MurA inactivates fully assembled Qβ 
phages and promotes degradation of Qβ genomic RNA. Instead, Reed argues that the location of 
rat mutations suggests A2 binds to the opening of the “mouth” of MurA when MurA is closed 
and singly liganded, locking MurA in a closed conformation and preventing further synthesis of 
UDP-GlcNAc-EP.  The presence of a hydrophobic patch surrounded by hydrophilic residues on 
the proposed A2-MurA binding site and binding assays showing that A2 binds preferentially to 
the singly liganded state support this argument [26]. 
 
The timing of lysis is instead regulated by the amount of Qβ RNA. A2 is synthesized in levels 
about three-fold that of MurA and largely exists bound to Qβ RNA, limiting the amount of free 
A2 available to bind to MurA [26]. 
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The lysis protein L of phage MS2 
The lysis gene L overlaps with MS2 coat and replicase genes and encodes a 75 amino acid IM 
protein with a C-out, N-in topology (figure 3). Unlike the lysis proteins of other prototypical 
small lytic phages, L does not cause septal lysis. Instead, L causes random blebbing in which the 
cell bulges out at random locations before lysing (figure 1) [27]. This is the first indication that 
L-mediated lysis occurs through a mechanism other than inhibition of PG biosynthesis. 
Additionally, the average glycan strand length and extent of crosslinking decrease upon L-
mediated lysis, suggesting that L functions by activating host autolysins normally involved in PG 
degradation during PG biosynthesis [28]. This mechanism continues to be investigated. 
 
Phage M 
The continued increase in antibiotic resistance necessitates the discovery of novel antibiotics and 
their targets. As the three prototypical small lytic phages display great diversity in their lysis 
mechanisms, studying the lysis proteins of other small phages may lead to the discovery of novel 
lysis mechanisms that can be applied to the development of antibacterial therapies. The lysis 
proteins of Leviviridae phages have evolved in three genetic architectures: separate from all 
other genes as in AP205, overlapping with the coat and replicase genes in a +1 reading frame as 
in MS2, and embedded in the +1 reading frame of the replicase gene as in M. We therefore chose 
to study the lysis proteins of Leviviridae phages, reasoning that the wide range of genetic 
architectures suggests a similar range in lysis targets [29]. 
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In particular, we studied M Lys, the lysis protein of phage M. Phage M was isolated from sewage 
in South Africa in the early 1980s and adsorbs to pili encoded by the IncM plasmid. As the IncM 
plasmid can be found in multiple bacterial strains, phage M can infect various IncM-containing 
strains of Escherichia, Klebsiella, Serratia, Salmonella, and Proteus. M Lys is an IM protein 37 
amino acids long [29] with an N-out, C-in topology. Because of its similarities in both membrane 
topology and lysis phenotype to the lysis protein E, we hypothesized that M Lys inhibits PG 
biosynthesis. 
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CHAPTER II 
METHODS 
 
Bacterial strains, plasmids and growth conditions 
XL1-Blue (recA endA1 gyrA96 thi hsdR17 supE44 relA1 lac [F’::Tn10 proA+B+ 
lacIq Δ(lacZ)M15]) was used for the isolation of insensitive to M Lys (iml) mutants and 
nonfunctional M lys mutants. Additional strains used in this work are listed in Table A1 in 
Appendix A. 
 
Plasmids used in this work were constructed by a graduate student in the laboratory and are listed 
in Table A1 in Appendix A. 
 
Cultures were grown in lysogeny broth (LB) supplemented with 100 μg/ml ampicillin (Amp; 
RPI), 10 μg/ml chloramphenicol (Cam), 0.4% final arabinose (Ara), 1mM final isopropyl-β-D-
thiogalactopyranoside (IPTG; RPI), and 20 μg/ml final 5-bromo-4-chloro-indolyl-β-D-
galactopyranoside (X-Gal) where indicated. All chemicals were supplied by Sigma Aldrich 
unless otherwise indicated. 
 
Selection and screening for iml mutants 
A culture of XL1-Blue pBAD24 M Lys was grown to an A550 of 0.2, after which M Lys 
expression was induced with arabinose. Upon the completion of lysis 2 hours after induction, 
cells were collected from 10 ml of culture through centrifugation, resuspended in 100 μl LB, and 
plated on LB-Ara-Amp-IPTG-X-gal plates. To ensure lysis resistance and continued M Lys 
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expression, surviving blue colonies were isolated and subjected to the same selection and 
screening protocol. 
 
Selection and screening for nonfunctional M lys mutants 
M Lys was subjected to error-prone PCR using the GeneMorph® II Random Mutagenesis Kit 
(Agilent Technologies), cloned into the pBAD24 vector, and transformed into XL1-Blue cells. 
The selection and screening process used to isolate nonfunctional M lys mutants is identical to 
that described for iml mutants above. 
 
DNA sequencing 
Plasmid DNA was purified from cells using the QIAmp DNA Mini Kit (QIAGEN). The murJ 
locus in iml mutants was PCR amplified using the Phusion® High-Fidelity DNA polymerase 
(NEB) and primers listed in Table A2 in Appendix A. DNA was submitted to Eton Bioscience 
for Sanger sequencing. 
 
Lysis profiles 
Cultures were grown in LB-Amp or LB-Amp-Cam at 37°C to an optical density at 550 nm 
(OD550) of 0.2 to 0.6, and M Lys expression was induced with arabinose. Growth was monitored 
at OD550 until lysis was complete. 
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Crosslinking 
M Lys was crosslinked to neighboring molecules using maleimidobenzophenone (MBP), a 
heterobifunctional crosslinking reagent containing a sulfhydryl-reactive group and a photoactive 
group. 
 
A culture of TB28 was grown to OD550 0.6, induced with arabinose for 10 minutes, and 
harvested by a 15 minute centrifugation at 10,000 x g at 4°C. The pellet was resuspended in 1 ml 
minimal A buffer pH 7.2, and 100 μl of resuspension was added to a sterile well dish. 1 μl of 100 
mM MBP in dimethylformamide (DMF), or 1 μl of DMF for the mock treatment, was added. 
The reaction mixture was incubated in the dark for 30 minutes, after which 1 μl 1 M 
dithiothreitol was added to quench the reaction. The mixture was irradiated with 366 nm light for 
20 minutes and subjected to TCA precipitation for further analysis by SDS-PAGE and Western 
blotting. 
 
SDS-PAGE and Western blotting 
Protein samples were precipitated from 1 ml of culture or the crosslinking reaction mixture in 
10% TCA on ice for 20 minutes. Precipitated protein was pelleted down by a 10 minute 
centrifugation at 10,000 x g, washed in cold acetone, and resuspended in 10 μl 2X SDS BMS and 
10 μl 0.1 M Tris pH 3 10 M urea. Samples were boiled for 10 minutes before being loaded onto 
an appropriate gel (16.5% Tris-Tricine for analyzing M Lys expression and 4-20% Tris-Glycine 
for crosslinking experiments) and subjected to electrophoresis. Proteins were transferred from 
the gel to a nitrocellulose membrane using the appropriate apparatus (semidry transfer apparatus 
for analyzing M Lys expression and tank transfer apparatus for crosslinking experiments), 
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Membranes were incubated first in either anti-His (1:3,000; Sigma Aldrich) or anti-L (5’-
TPASTNRRRPFKHEDC; 1:3,000; Sigma Aldrich) and second in peroxidase anti-mouse 
produced in goat (1:3,000; Thermo Scientific). The SuperSignal® West Femto Maximum 
Sensitivity Substrate kit (Thermo Scientific) was used to develop the signal, and 
chemiluminescent imaging with ChemiDocTM XRS system (Bio-Rad) was used to detect the 
signal. 
 
In silico modeling 
The structure of MurJ was predicted using the I-TASSER server [30-33] based on a previous 
study showing that I-TASSER accurately predicted MurJ membrane topology and the location of 
the solvent-exposed central cavity [10]. 
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CHAPTER III 
RESULTS 
 
Selection of iml (insensitive to M Lys) mutants 
To identify the target of M lys, we sought to identify spontaneous mutants resistant to M lys-
mediated lysis. Mutations arising in any one or all of the following proteins might confer 
resistance to lysis: the target protein of M lys; chaperone proteins involved in M lys folding or 
insertion in the inner membrane; and proteins involved in M lys expression. Proteins involved in 
M lys expression provide no information on E. coli host factors involved in the lysis pathway, so 
these mutations were selected against (figure 4A). 
 
To avoid mutants that downregulate M lys expression, a modified protocol for alpha 
complementation was implemented. -galactosidase normally cleaves glycosidic bonds in -
galactosides such as lactose. This activity can be taken advantage of to visually mark cells 
displaying -galactosidase activity; intracellular cleavage of the lactose analog X-gal, for 
example, yields a blue substituted indole and therefore dyes cells blue. Linking M lys expression 
to -galactosidase assembly and plating cells on media containing X-gal, then, dyes cells 
expressing M lys blue. 
 
Towards this end, M lys and lacZ were cloned into the arabinose inducible pBAD24 in tandem 
and transformed into XL1-Blue cells containing lacZ on the IPTG inducible F’ plasmid. 
Because the two are genetically linked, M lys expression also results in lacZ expression. 
Separately, LacZ and LacZ are nonfunctional fragments of -galactosidase. In the presence of 
31 
 
each other, though, the two fragments spontaneously assemble to form functional -
galactosidase. Thus cells resistant to M Lys-mediated lysis can be selected and screened for blue 
colonies (figure 4B). 
 
 
Figure 4. A modified alpha complementation protocol was used to select iml mutants 
(A) Mutations in two types of proteins can give rise to lysis resistance: proteins involved in M Lys expression and 
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proteins involved in the lysis pathway. Mutations of proteins involved in the lysis pathway were selected for. 
(B) LacZα expression was linked to M Lys expression. Subsequent LacZω expression from the F’ plasmid resulted 
in the spontaneous assembly of functional β-galactosidase which, when paired with X-gal, yields blue cells. 
 
Cultures were grown in LB-Ampicillin broth. Lysis was induced with arabinose at A550 0.2 – 0.6 
and survivors were collected and plated on LB-Ampicillin-Arabinose-IPTG-X-gal agar plates 
(figure 5). Eleven blue colonies have been isolated so far. 
 
 
Figure 5. Upon iml mutant isolation, lysis resistance and continued M Lys expression were verified. 
 
To verify that iml mutants do not downregulate M lys expression, M lys levels in the iml mutants 
were visualized through Western blotting. Mutant lysis profiles were also generated to ensure 
resistance to M lys-mediated lysis (figure 5). Of the eleven blue colonies selected, M Lys 
expression and lysis resistance have been verified in iml 1, 2, 3, and 4 (figure 6). 
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Figure 6. Insensitive to M lysis (iml) mutants display resistance to M lys-mediated lysis 
(A) Cultures of wild type (red) and iml mutants 1 (blue), 2 (green), and 3 (black) carrying M lys-his6 in plasmid 
pBAD24 were induced at A550 = 0.6. 
(B) Trichloroacetic acid (TCA) precipitation of cultures was analyzed by SDS-PAGE and immunoblotting with anti-
His antibody. Mutants accumulated similar levels of M Lys-His6 as the wildtype. 
 
The iml mutants contain substitutions mutations in MurJ 
 
Work done in parallel by a graduate student in the lab has indicated that MurJ, a flippase in the 
peptidoglycan biosynthetic pathway that flips lipid II from the cytoplasm into the periplasm 
might be the target of M Lys. Briefly, he isolated multiple clones of murJ that provided 
protection against M Lys in a multi-copy suppression assay. Based on this new information, the 
murJ locus from iml mutants was therefore amplified using PCR and sequenced. 
 
Each iml mutant yielded a murJ mutation except iml 4 and 11 (table 1). PCR amplification 
products from these mutants yielded low quality sequencing, so murJ in these mutants will be 
amplified via PCR and sequenced again. 
 
In the mutants that yielded high quality murJ sequencing, seven unique substitution mutations 
were found, two located on TMD 2 and five located on TMD 7 (table 1, figure 7). Furthermore, 
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TMD 7 mutations are located every four residues, indicating that they map on the same face of 
the -helix, thus providing strong evidence for an M Lys interaction interface with the TMD 7 of 
MurJ. 
 
 
Table 1. iml mutations were found in TMDs 2 and 7 of MurJ. 
 
One issue encountered while selecting spontaneous iml mutants is the reappearance of the mutant 
I248S (table 1). To avoid consistently selecting iml mutants with the same mutation, selected iml 
mutants will be subjected to chemical mutagenesis via EMS and other chemical and physical 
mutagenic agents. The resulting mutants will be subjected to the same selection process as used 
above. 
 
Selection of M lys mutants 
To identify the specific M Lys amino acids involved in lytic activity, M lys was subjected to 
error-prone PCR, cloned into empty vectors in tandem with LacZ, and transformed into XL1-
Blue cells. Nonfunctional mutants were selected using the same selection process as used above 
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(figure 5). Lysis profiles will be generated and M Lys expression verified through Western 
blotting in the future. 
 
Figure 7. MurJ sequence and location of isolated mutations. 
 
Substitution mutations in M lys mutants 
More than twenty M lys mutants have been isolated at this time, five of which contain one of the 
following substitution mutations: N6K, A16P, I20K, S25L, and V32E (figure 8). As M Lys is a 
predicted -helical transmembrane protein, disrupting transmembrane hydrophobicity or 
structure interferes with M Lys insertion in the membrane and thus enables lysis resistance. This 
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is exemplified by the mutants N6K, A16P, and I20K. N6K and I20K introduce a positively 
charged residue to the transmembrane domain. As the inner membrane is a hydrophobic 
environment, the presence of charged molecules is thermodynamically unfavorable and unlikely 
to occur. A16P introduces proline to the transmembrane domain. Because proline is a cyclic 
amino acid, the bond angles in its backbone are fixed and not conducive to forming -helices. 
The amine group on proline residues is also incapable of forming the hydrogen bonds necessary 
to form -helices. A kink in the -helix therefore forms when proline is present. 
 
Changing the charge of either terminus relative to the other could also confer lysis resistance to 
host cells. The cytoplasm is negatively charged compared to the periplasm, so inner membrane 
proteins tend to orient with the positive terminus located inside the cytoplasm. Both termini in M 
lys have a +1 charge. The C terminus, however, have two positively charged residues while the 
N terminus has one. It can therefore be predicted that M lys has an N-out, C-in topology. 
Assuming this prediction is correct, M Lys variants with mutations like V32E that neutralize the 
charge of the C terminus will have an inverted membrane topology and thus impaired M lys 
function. To verify M lys membrane topology, charged tags can be fused to either M lys 
terminus and lysis profiles established. Tags accentuating the charge differences between the 
termini should result in continued M lys function, and tags reversing the charge differences 
should result in impaired M lys function. 
 
The mutant S25L does not affect the transmembrane domain or change the charge of either 
terminus. This mutation, then, may prevent M lys-mediated lysis by affecting M lys interaction 
with MurJ. 
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Figure 8. M Lys-His6 sequence and location of isolated mutations. 
Amino acid residues highlighted in red and blue are positively and negatively charged, respectively, at physiological 
pH. Underlined residues make up the transmembrane domain. 
 
M Lys crosslinking studies 
MBP contains a sulfhydryl-reactive group and a photoactive group which allow for its use as a 
crosslinking agent. M Lys contains one cysteine residue, Cys10, and so can react with MBP at 
one location. Cys10 lies within the transmembrane domain. Site directed mutagenesis was used to 
create the mutant M Lys C10S, which serves as a negative control. The wildtype M Lys serves as 
a positive control. All M Lys variants were tagged with 6XHis and L2-36 to allow for 
visualization during Western blotting. 
 
E. coli of various iml mutants were transformed with a pBAD33 vector carrying one of the two 
M lys mutants. After selecting for cells containing pBAD33, cultures were grown to a desired 
OD and M lys expression induced. Samples were collected prior to lysis and subjected to MBP 
crosslinking, and crosslinked proteins were visualized using Western blotting. 
 
The outcomes from the resulting Western blot are inconclusive. No bands appear in wildtype 
cells transformed with M lys C29S containing vectors, indicating a lack of M lys expression. This 
sample was therefore disregarded from further analysis. Background bands appear in the 
negative controls (empty pBAD33 vector, incubation with DMF instead of MBP, and M lys 
C10S C29S). Interestingly, the M lys C10S C29S negative controls display bands at molecular 
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weights corresponding to M Lys crosslinked with MurJ. These bands may simply be background 
bands, though, because the same band appears in the empty pBAD33 sample (figure 9). 
 
To avoid the presence of background bands, FLAG-tagged MurJ will be used instead of His-
tagged M Lys in future crosslinking experiments.  
 
 
Figure 9. M Lys crosslinking experiments yield inconclusive results. 
Trichloroacetic acid (TCA) precipitation of cultures was analyzed by SDS-PAGE and immunoblotting with anti-L 
antibody. The presence of background bands makes it difficult to draw conclusions from this blot. 
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CHAPTER IV 
DISCUSSION/CONCLUSIONS 
 
As a small lytic phage of the Leviviridae family, phage M has evolved a single stranded RNA 
genome encoding four genes, only one of which is involved in host lysis. Similarities in lysis 
phenotype and membrane topology between E and M Lys suggested that M Lys, like E, effects 
lysis by inhibiting PG biosynthesis. Here we have used a genetic approach to identify the M Lys 
target protein and, in doing so, provide support for the identity of the E. coli lipid II flippase. 
 
Using a modified alpha complementation protocol, we identified host mutants resistant to M 
Lys-mediated lysis, henceforth referred to as iml mutants. A multi-copy plasmid suppression 
expressing SauIIIA1 digests of the E. coli genome rescued cells from lysis upon expression of 
either the arabinose exporter YdeA or the proposed lipid II flippase MurJ (K. R. Chamakura and 
R. Young, unpublished). We hypothesize that YdeA rescues cells from lysis by exporting 
arabinose before it can activate the araBAD promoter linked to M lys and induce expression. 
MurJ, on the other hand, rescues cells from lysis through an unknown mechanism. The simplest 
explanation is that M Lys targets and inhibits MurJ, and overexpressing MurJ from a multi-copy 
plasmid rescues MurJ function. 
 
Based on these results, we sequenced the murJ locus in isolated iml mutants and observe single 
substitution mutations in MurJ, although two mutants yielded low quality sequencing and need to 
be re-sequenced. Interestingly, two mutations map to the same face of MurJ TMD 2 and five to 
the same face of TMD 7 (figure 10), outlining the M Lys-MurJ interface essential to M Lys 
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function. Mutation of this interface presumably weakens M Lys-MurJ interactions, thus lending 
lysis resistance to the host cell. This in turn suggests a possible lysis mechanism for M Lys 
function. MurJ has a positively charged central cavity and, as a member of the MATE family, 
has been proposed exist in two V-shaped conformations with the central cavity exposed to either 
the cytoplasm or the periplasm. In the current model for MurJ-mediated lipid II flipping, MurJ 
binds to lipid II in the cytoplasmic leaflet, changes conformations, and releases lipid II into the 
periplasmic leaflet. The location of the iml mutations suggests that M Lys interacts with MurJ 
along TMDs 2 and 7, locking MurJ into one conformation and preventing further flipping 
activity. 
 
 
Figure 10. Location of iml mutations on I-TASSER model structure of MurJ 
(A) Front view from within the membrane plane. The central cavity of MurJ is open to the periplasm in this 
conformation. 
(B) View from the periplasm. 
 
Our results support the identification of MurJ as the E. coli lipid II flippase. Based on similarities 
to the lysis protein E in membrane topology and lysis phenotype, we predicted that M Lys 
inhibits an IM enzyme involved in PG biosynthesis; both M Lys and E have an N-out, C-in 
topology, and both cause septal lysis, a lysis phenotype also seen in penicillin-mediated lysis and 
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associated with inhibition of PG biosynthesis. We have shown here that M Lys targets MurJ, 
implicating MurJ in PG biosynthesis. The only proposed function of MurJ in PG biosynthesis is 
that of the lipid II flippase. Additionally, we address the concerns of background noise 
obfuscating FtsW-mediated lipid II flipping in the colM assay developed by Sham et al., 2014. 
M Lys expression from one plasmid either causes cell lysis in wildtype E. coli cells or doesn’t 
affect cell density in iml mutants with no intermediary phenotypes (figure 6) 
 
M Lys overexpression from two plasmids, interestingly enough, causes reduced lysis in iml 
mutants (data not shown), suggesting that a single mutation in the M Lys-MurJ interaction 
interface is not enough to completely block M Lys-MurJ interaction. While the M Lys-MurJ 
interaction is weak enough in iml mutants to allow for continued MurJ function when M Lys is 
expressed from a single plasmid, overexpressed M Lys overwhelms the amount of MurJ present 
in a host cell through sheer numbers and inhibits MurJ function, leading to reduced lysis. 
 
Future Work 
We now have genetic evidence suggesting that M Lys interacts with and inhibits MurJ. However, 
biochemical evidence for the M Lys-MurJ interaction remains to be elucidated. Two common 
methods of demonstrating protein interaction are in vivo crosslinking and co-
immunoprecipitation. We began the process of identifying interacting proteins using MBP, a 
 heterobifunctional crosslinking reagent with a sulfhydryl-reactive group and photoactive group, 
The presence of background bands interfered with interpretation, however, and reaction 
conditions remain to be optimized. The use of reagents similar to MBP but with differing arms 
lengths will allow the interaction distance between M Lys and MurJ to be deduced. 
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Alternatively, appropriate affinity columns can be used to purify the 6XHis-tagged M Lys or 
FLAG-tagged MurJ variants used. 
 
Our work here has also established a new class of antibiotics that target flippases, of which M 
Lys is the first known member. Furthermore, the presence of MurJ homologs in all cell wall 
synthesizing bacteria implicates M Lys in a possible role as a broad spectrum antibiotic. M Lys 
function must first be tested in other bacteria to verify that function is indeed conserved among a 
range of MurJ homologs, and M Lys specificity to MurJ must be determined. M Lys itself, 
however, cannot be used as a clinical antibiotic due to its inability to diffuse across the cell 
membrane, and so small molecules capable of diffusing into a cell and acting along the same 
mechanism must first be developed. Toward this end, a greater understanding of the MurJ 
mechanism and how M Lys inhibits it is necessary. The use of various mutagenesis protocols, 
such as error-prone PCR and site-specific mutagenesis, to identify nonfunctional M Lys mutants 
could aid in the identification of M Lys residues critical for function. Additionally, various M 
Lys truncations could be tested to determine the minimal inhibitory domain. 
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APPENDIX A 
Table A1. Strains and plasmids 
Strain Relevant genotype a Source or Reference 
MG1655 ilvG rfb50 rph1 [34] 
TB28 MG1655, lacIZYA<>frt [wt] [35] 
Construct Relevant genotype a  ori Source or Reference 
Plasmids:    
pBAD33 cat araC PBAD:: pACYC [36] 
pRY34353 cat araC PBAD::M lys-his6 lacZα pACYC This work 
pBAD24 bla araC PBAD:: ColE1 [36] 
pRY34354 bla araC PBAD:: M lys-his6 ColE1 This work 
pRY34355 bla araC PBAD:: M lys-his6 lacZα ColE1 This work 
 
Table A2. Primers used to amplify the murJ locus in iml mutants. 
Primer name  Sequence 
MurJ forward 5’ GAA TAA ACC CTG TAA CAT CTG GCG G 3’ 
MurJ int forward 1 5’ ATC ATG GTG ACC GCG CCA GGC TTC GCT GAC 3’ 
MurJ int forward 2 5’ CTT GCT TCC GGT TCG GTG TCT TGG ATG 3’ 
MurJ int reverse 1 5’ CGG GGT AAA GAT TTT CTG CTT ACG C 3’ 
MurJ reverse 5’ ACC GCA TCA GGA ACC GAC GCT ATA TG 3’ 
 
